The Circulating Tumor Cells Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Circulating Tumor Cells Market?
The market size of circulating tumor cells has seen quick growth lately. In recent years, it rose from $11.9 billion in 2024 to $13.37 billion in 2025. This reflects a compound annual growth rate (CAGR) of 12.4%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Circulating Tumor Cells Industry?
The Circulating Tumor Cells market size is predicted to reach $21.68 billion by 2029, with a compound annual growth rate (CAGR) of 12.8%.
Download Your Free Sample of the 2025 Circulating Tumor Cells Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Circulating Tumor Cells Market?
The key drivers in the circulating tumor cells market are:
• Increased adoption of point-of-care CTC testing and microfluidics
• Concentration on identification and treatment of rare cancer types
• Standardization of Circulating Tumor Cell (CTC) assays
• Expansion and advancements in CTC-based clinical trials
Global Market Segmentation: Identifying Major Circulating Tumor Cells Industry Segments
The circulating tumor cells market covered in this report is segmented –
1) By Product: Kits And Reagents, Blood Collection Tubes, Devices Or Systems
2) By Technology: CTC Enrichment, CTC Detection, CTC Analysis
3) By Specimen: Blood, Bone Marrow, Other Body Fluids
4) By Application: Clinical Or Liquid Biopsy, Research
Pre-order the 2025 Circulating Tumor Cells Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Circulating Tumor Cells Market?
The key trends in the circulating tumor cells market are:
• Innovations in CTC isolation techniques are a notable emerging trend.
• Governmental funding for circulating tumor cells (CTC) research is increasingly shaping the future of the market.
• Advancements in CTC detection technologies are a critical trend.
• The integration of CTC analysis with artificial intelligence (AI) and liquid biopsy for cancer monitoring are significant emerging trends.
Who Are the Top Competitors & Leading Players in the Circulating Tumor Cells Market?
Major companies in the circulating tumor cells market are:
• Precision Medicine Group LLC
• Bio-Techne Corporation
• BIOCEPT Inc.
• Creativ MicroTech Inc.
• Fluxion Biosciences Inc.
• Ikonisys Inc.
• Qiagen N.V.
• ScreenCell SAS
• STEMCELL Technologies Inc.
• Sysmex Corporation
• Aviva Biosciences Corporation
• LungLife AI Inc.
• Miltenyi Biotec GmbH
• Menarini Silicon Biosystems S.p.A.
• Canopus Bioscience Ltd.
• IVDiagnostics Inc.
• BioFluidica Inc.
• Biolidics Limited
• Rarecells Diagnostics SAS
• LineaRx Inc.
• Thermo Fisher Scientific Inc.
• Greiner Bio-One International GmbH
• Stanford Research Institute International
• Agilent Technologies Inc.
• Resolution Bioscience Inc.
• Cynvenio Biosystems Inc.
• ApoCell Inc.
• Clearbridge BioMedics Pte. Ltd.
• Celsee Inc.
• RareCyte Inc.
• On-chip Biotechnologies Co. Ltd.
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the circulating tumor cells market in 2024
